Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial
- 15 December 1980
- Vol. 46 (S12), 2805-2808
- https://doi.org/10.1002/1097-0142(19801215)46:12+<2805::aid-cncr2820461413>3.0.co;2-h
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapyCancer, 1980
- Estrogen-receptor status and response to chemotherapy in early and advanced breast cancerCancer Chemotherapy and Pharmacology, 1980
- Adjuvant chemotherapy of breast cancerCancer, 1979
- Estrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1978
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976